A randomized, controlled clinical trial was conducted on 72 patients undergoing elective cardiac surgery to compare patientcontrolled analgesia (PCA) to nurse-titrated infusion of morphine. Pain and nausea scores were assessed at 5, 20, 32 and 44 hours after cardiopulmonary bypass. Serum cortisol estimations were performed at 24 and 48 hours, and morphine consumption was measured at 0-24 and 24-48 hours. There was no difference between pain scores (P=0.72), nausea scores (P=0.52), serum cortisol at 24 and 48 hours (P=0.32 and P=0.34), and morphine consumption at 0-24 and 24-48 hours (P=0. 16 and P=0.12). There was also no difference in the time to tracheal extubation (P= O. 79) and discharge from fCU (P= 0.64). There was a significant association between pain and serum cortisol at 48 hours (P= 0.023). This study also found a tenfold difference in the amount of morphine used (range = 11 to 108 mg), with no significant association with patient age or sex. We could find no significant benefit from the routine use of PCA in cardiac surgical patients.
Postoperative pain is a major concern for patients about to undergo surgeryi2. Despite the many drugs and techniques available, adequate pain relief is often not achieved'·5. For patients recovering from cardiac surgery this may lead to increased levels of stress hormones, increased myocardial oxygen consumption (with risk of myocardial ischaemia), difficulty with mechanical ventilation and risk of barotrauma, and restricted mobility (including ability to breathe deeply and clear secretions). This may delay the discharge of patients from the intensive care unit (lCU) and ultimately from the hospital. Effective pain control has been shown to reduce the incidence of major infections, cardiovascular failure and duration of mechanical ventilation in both high-risk surgical and cardiac surgical patientso. 7 • Patient-controlled analgesia (PCA) has been shown to improve pain relief and reduce Accepted for publication on August 17, 1994. analgesic requirements in many general surgical patients' and may reduce hospital costs 9
• This prospective, randomized study was designed to compare PCA with our standard method of postoperative pain relief (nurse-controlled, titrated infusion of morphine) in patients following cardiac surgery.
MATERIALS AND METHODS
After Ethics Review Committee approval and written, informed consent, 72 patients over the age of 34 years booked for elective cardiac surgery were enrolled in the study. High-risk patients, defined as a Clinical Severity Score greater than 610, were excluded because of the increased likelihood of prolonged ventilation, sedation and ICU stay. Patients were also excluded if they were taking other analgesic medications, including nonsteroidal anti-inflammatory agents, antidepressants and Class 1 antiarrhythmics. Patients were excluded postoperatively if they had significant inotrope requirements (adrenaline > 5p.gl min), returned to operating theatre for re-exploration, had a neurological deficit preventing assessment, or died within 48 hours.
All patients received a standardized general anaesthetic consisting of: 1. premedication: temazepam 10-20 mg, morphine 5-10 mg or papaveratum 10-20 mg (converted to morphine equivalents for comparison) Anaesthesia and Intensive Care, 1"01. 22 , No. 6, December, 1994 and hyoscine 0.2-0.4 mg; 2. induction: diazepam 5-10 mg, fentanyl 500-1500 p,g and pancuronium 6-12 mg; 3. maintenance: fentanyl 500-1500 p,g, diazepam 5-10 mg, enflurane 0.2-1.00/0, with variable increments of propofol during cardiopulmonary bypass (CPB). Patients were ventilated with a tidal volume of 10 mllkg, adjusting respiratory rate to an end-tidal carbon dioxide of 32-34 mmHg. Vasopressor agents were used when clinically indicated. CPB was standardized using a crystalloid!colloid prime, membrane oxygenator, moderate hypothermia (to 27 QC) and alpha-stat pH management.
Patients were transferred to ICV intubated and mechanically ventilated following completion of surgery. Patients were weaned from mechanical ventilation when they responded to verbal stimuli, had rewarmed, and achieved haemodynamic stability with satisfactory blood loss (less than 100 mllhr). Extubation occurred following review by the intensivist. Patients were transferred from ICV after a period of stability, which for most routine cases occurred the morning after surgery.
Postoperative pain and nausea were assessed at the following predetermined times following return to ICV: 5, 20, 32 and 44 hours after cardiopulmonary bypass (CPB). After initial pilot testing, it was found that a visual analogue scale was unsuitable for this patient population, particularly in the early postoperative period. Hence, intensity of pain and nausea were assessed on an ordinal scale: o = no pain/nausea 1 = mild pain/nausea 2 = moderate pain/nausea 3 = severe pain/nausea 4 = unbearable pain (for nausea = vomiting) If the patient was asleep at the predetermined time for assessment, they were assumed to have no pain or nausea.
PCA was new to our unit, so an educational programme and initial familiarization period were established before commencement of the trial. Morphine was used for both the nurse-controlled titrated infusion (= STD Group) and PCA infusion (= PCA Group), and was commenced when the patient responded to verbal commands and were able to complain of pain (non-verbally, if still intubated). The Lifecare 4200 PCA device (Abbott Australasia Pty Ltd, Kurnell, N.S.w.) was programmed to deliver a dose of morphine 1.0 mg, with a lockout interval of five minutes; no background infusion or dose limit was used. The STD Group were managed with a morphine infusion delivered via a burette containing morphine 0.25 mg/ml, titrated by the nurse using a Dosi-Flow infusion rate controller (Leventon, s.a. Sant Andreu de la Barca, Spain). Both groups were able to have their analgesia converted to oral paracetamol, with or without codeine, when the nursing/medical staff considered the patient no longer required morphine.
Morphine consumption was calculated for the initial 24 hours (0-24 hours) and second 24 hours (24-48 hours).
The time to extubation and ICV discharge from the completion of CPB were recorded. Delays in extubation or discharge from ICV not related to postoperative analgesia (sepsis, inotrope requirements, or administrative) were accommodated by using a maximum value for extubation of 24 hours, and for ICV discharge of 48 hours.
Blood was taken for serum cortisol concentration at 24 and 48 hours after CPB and measured using the TDX method (Abbott Laboratory, Abbott Park, IL 6006X, U.S.A.).
Because pain is a subjective phenomenon, with analgesic requirements strongly associated with patient age, randomization was by stratification (35-60 years, and >60 years) and blocking, to maximize equality of age for both groups. Because of the nature of postoperative pain and its control, it was both impractical and unethical to blind analgesic administration. The lack of effect expected from a PCA-delivered placebo would be quickly appreciated by the patient and staff. To minimize the effect of observer bias, all outcome assessments were predetermined and objective. Because detailed instructions were required for the patient to understand and operate a PCA pump postoperatively, randomization occurred before informed consent (i.e. Zelen protocol) ". This removed unnecessary details being discussed with those patients randomized to the conventional therapy group and their confusion postoperatively. It also enabled adequate discussion of the patient's allocated method of analgesia during the preoperative visit.
A preliminary estimate of sample size was based on an average pain score of 24 mm, and for PCA of 18 mm (i.e. 25% improvement), with a standard deviation of 8 mm. With a type I error of 0.05 and a type 11 error of 0.2, the required number was calculated at 74 patients (Clinical Trials Design Program V1.0, Biosoft, Cambridge, U.K.). Although we changed our outcome assessments to an ordinal scale, we did not adjust our sample size calculation.
Pain and nausea scores were analysed using Friedman's two-way analysis of variance 12. Independent data were compared using unpaired Student's t test or Mann-Whitney V test, as appropriate. Multivariate analyses were also performed using linear regression (averaged pain score, morphine usage) or logistic regression (sex). All statistical analyses were "intention-to-treat" and performed using SPSS/PC + V 4.0 software (SPSS Australasia Pty Ltd, Sydney). Data is presented as mean (standard deviation, SD), unless indicated. A P value of less than 0.05 was considered significant. No correction was made for multiple comparisons.
RESULTS
A total of 72 patients were enrolled in the study; there were two deaths (one intraoperative and one postoperative) and one cerebrovascular accident during the study period. Data was incomplete for 16 patients because of protocol violation (e.g. use of other analgesic or nonsteroidal agents), staff misunderstanding, significant inotrope requirements or transfer to another hospital during the study period (this usually occurred in the second 24 hour period, with loss of pain and nausea scores). Of the 69 patients analysed, there were 53 male (77<170) and 16 female (23<170), with an average age of 62.8 (8.6) years. The average time of surgery was 267 (73) minutes, time to extubation (from the end of CPB) 12.8 (5.5) hours and time to ICU discharge 31.4 (13) hours. The average morphine consumption in the 48 hour trial period was 54.4 (25) mg and ranged from 11 to 108 mg. No patient in either group had significant respiratory depression after commencment of morphine analgesia.
The stratified randomization process resulted in similar patient and operative characteristics (Table 1) , though there was some imbalance between sex and weight (i.e. more males in the PCA Group, with greater weight). Importantly, the intraoperative doses of fentanyl were similar, as was the type and duration of surgery, use of internal mammary artery and leg vein harvesting. All patients consented to the trial after being approached with knowledge of their allocated treatment: no patient withdrew consent during the trial.
There was no significant difference between the groups for pain scores at the specified time periods after CPB (Figure 1 ). There was also no significant difference for nausea scores (Figure 2 ). Overall pain score, assessed at the end of the 48 hour study period, was similar when rated by the patient (PCA Group = 1.4, STD Group = 1.1, P = 0.14) and nurse (PCA Group = 1.1, STD Group = 1.3, P = 0.23). The amount of oral analgesia use was similar (W = 142, P = 0.92). There were eight episodes where patients (n = 5) rated their pain as severe or unbearable; three of these occurred in the PCA Group and five episodes with the STP Group.
Morphine consumption during the two time periods was not significantly different. At 0-24 hours PCA Group = 25.4 mg (SD 14) and STD Group = 20.1 mg (SO 10) (P = 0.16); at hours peA Group = 34.8 mg (SO 19) and STO Group = 26.6 mg (SO 15) (P = 0.12) (Figure 3 ). Serum cortisol concentrations were also similar: at 24 hours peA Group = 766 nmolll (SO 370) and STD Group = 850 nmolll (SO 260) (P = 0.32); at 48 hours peA Group = 685 nmolll (SO 361) and STD Group = 601 nmolll (SO 270) (p = 0.34) (Figure 4 ).
There was also no difference between the groups in time to extubation [peA Group vs STD Group: 13.0 hours (SO 5.9) vs 12.6 hours (SO 5.0) (P = 0.79)] or leu discharge 32.2 hours (SO 12) vs 30.6 hours (SO 13) (P = 0.64) ( Figure 5 ).
There was no significant association between morphine dose at 0-24 hours and patient or operative factors. There was an association between morphine consumption at hours and BSA (r = 0.48, P<O.Ol) and weight (r = 0.48, P<O.OOI), and a 60. negative association with age (r = -0.42, P<O.Ol) and time to extubation (r = -0.53, P<O.OOl). However, when adjusted for confounding by multiple regression, all these factors became nonsignificant, with age and intraoperative fentanyl dose becoming effect-modifiers (P = 0.04).
When an averaged pain score was used in a multivariate regression analysis, a relationship between pain and serum cortisol at 24 hours (P = 0.087) and 48 hours (P = 0.023) was found. Age and sex were not significant in this model. Similar multivariate analyses showed there was no difference between males and females with respect to intraoperative fentanyl dosage (P = 0.24), postoperative morphine consumption at 24 hours (P = 0.95) and 48 hours (P = 0.71), serum cortisol levels at 24 hours (P = 0.80) and 48 hours (P = 0.18), time to extubation (P = 0.69) or discharge from leu (P = 0.30).
DISCUSSION
This study failed to demonstrate a benefit with the use of PCA, when compared to nurse-controlled infusion of morphine in postoperative cardiac surgical patients. Both pain and nausea scores were similar, as was total morphine consumption. Serum cortisol estimations, used as a marker of "stress", were also similar between groups.
To the authors' knowledge, there are no previous controlled studies comparing peA with parenteral opioid administration in cardiac surgical patients in the peer-reviewed literature. An abstract from Cleveland Clinie D compared PCA morphine with their conventional therapy (nurse controlled I-VI I-M morphine, followed by oral analgesics). They also found pain scores were similar between groups, but found that PCA resulted in a significantly lower incidence of severe pain. Unlike our study, their study commenced at the time of extubation and continued for 72 hours. Also, the PCA group were programmed to a [15] [16] [17] [18] [19] [20] minute lockout period, which would not be current practice. Aitken et all' used PCA in evaluating two formulations of dihydrocodeine in cardiac surgical patients (with a three-minute lockout period), but PCA was not evaluated explicitly. They reported on ward staff attitudes in a later paper 9 , concluding that PCA was well received and resulted in good analgesia, though there were some reservations concerning patient understanding and co-operation.
Good pain control leads to lower morbidity in a variety of major surgical procedures 6 • ll , including cardiac surgery7. 16 . In many studies, measurement of various hormones has been used as a surrogate marker of perioperative stress (i.e. the "stress response")6.l7l9. When compared with morphine infusion, EI-Baz and Goldin 17 found that epidural morphine reduced levels of serum cortisol and {3-endorphin in cardiac surgical patients. In our study, we did not find any difference in serum cortisol between the two groups. This is most likely due to the similar pain scores, as we also found a significant association between serum cortisol and pain intensity.
Although morphine consumption was similar for both groups, there was a suggestion of greater usage in the PCA group. However, many patients in the standard group had their morphine ceased and converted to oral analgesia earlier, whereas most patients in the PCA group continued morphine until the end of the trial period. This would bias the PCA group towards an apparent increased morphine consumption. The more important finding from this study was the tenfold difference in morphine requirements, ranging from 11 to 108 mg for the 48-hour trial period.
There are many reasons why this study failed to find a benefit from PCA in cardiac surgical patients. We may have failed to detect a real difference (i.e. type 11 error); however, sample size calculations were performed before commencement of the study and there was no suggestion of benefit in the results. A larger study is unlikely to contradict these findings. However, our major endpoint was pain at rest. We may have achieved greater sensitivity using pain on movement, or with deep breathing and coughing. Patients also had variable ability and understanding of the requirements of PCA, particularly in the early postoperative period, when they were confused or too weak to operate the demand button. This could be corrected in future studies by incorporating an initial background infusion, or accepting "nurse-assisted" PCA until the patient was more able to co-operate. Patients were rated as having no pain or nausea when asleep: other investigators have chosen to average the preceding and following scores to more fairly rate the expected level of pain and nausea. The different approaches could be argued, but we chose the former method as some patients had not awoken by the first measurement, or slept frequently during the early recovery period. It also needs to be appreciated that overall pain management in our cardiothoracic ICU was optimized by patients receiving experienced one-to-one nursing care, with the nurse able to titrate infusion analgesia. Owen et apo have pointed out that infusion analgesia can be successful if managed by attentive medical and nursing staff. Other studies comparing PCA have also found that nurse-administered analgesia is of equal efficacy2l2]. It could therefore be argued that this study supports increased staff education and involvement to optimize postoperative analgesia. Although we did not set out to monitor the nursing time required for both groups, our nursing staff felt that PCA required a longer set-up time; there was also a general feeling that patients were often unable to cope with the demands of PCA in the early stages of their recovery, particularly if elderly or confused. However, PCA was well-received later in the patient's recovery and was found to be less demanding of nursing time, with a particular benefit before removal of chest drains.
Pain control and sedation is difficult after cardiac surgery, as there are competing forces such as a reluctance to administer opioids because of the need for the patient to awaken and be ready for extubation and impaired cardiorespiratory and hepatic function. Patient age, differences in pain perception and the enormous pharmacokinetic and pharmacodynamic variability in this population further complicate their management 2 • 27 . Inadequate pain relief may lead to agitation, tachycardia and hypertension; this may lead to myocardial ischaemia and prevent ventilator weaning Anaesthesia and Intensive Care, ~ol. 22, No. 6, December, 1994 and extubation. Ideal pain management for these patients relies on adequate preoperative explanation, as well as individualizing their pain therapy. PCA may play a role in selected patients, but this study does not support its widespread use. Mahler and Kulik 28 found that patients who expressed a greater desire for information and behavioural involvement before coronary artery surgery experienced less pain, more ambulation and shorter hospital stay. Such patients would be expected to welcome PCA. However, other patients are threatened by personal responsibility in the unfamiliar environment of a hospital, particularly when undergoing major surgery29. They may prefer to be "looked after", leaving control of pain to the nursing and medical staff. It is these patients who may not tolerate PCA.
Interestingly, this study found that neither age nor sex were significantly associated with morphine consumption. This is in contrast to a study by Burns et al from Glasgow 30 , where they studied the influence of patient characteristics on requirements for morphine after upper abdominal surgery. They found that males required more morphine than female patients and older age was associated with decreased requirements. Zacharias et aF 2 found a negative correlation between age and morphine consumption in a group undergoing major abdominal surgery (mostly midline cholecystectomy). However, studies such as these are confounded by many other variables (e.g. body weight, BSA, use of intraoperative opioids). By using multivariate regression analyses, we were able to identify confounding and could find no signficant association.
In this study we used an uncommon randomization procedure, known as prerandomization, or Zelen protoco}1l.3l, whereby the patients are randomized before consent. This has the advantage of approaching potential trial participants with a knowledge of their treatment allocation. It may therefore increase recruitment, and in this study, clarified expectations for the patients who were to get different methods of postoperative analgesia. The major flaw of this randomization procedure is that selection bias may be introduced into the study if patients are more likely to accept one treatment over the other 31 • This did not occur and such a procedure may be useful in future anaesthetic studies where the treatment arms are significantly different and require detailed explanation. However, ethical issues also exist and we would stress that patients should be free to withdraw from participating in a trial at any stage, irrespective of whether they still receive the allocated treatment.
In conclusion, this study found no benefit from the use of PCA in postoperative cardiac surgical patients. 
